Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Cuker

Showing results (121-130 of 258) with videos related to

Pageof 26
Sort By:
Thrombosis and Haemostasis|January 31, 2014
Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgeryAdam Cuker, Lubica Rauova, Douglas Bolgiano, et al.
Pharmacoepidemiology and Drug Safety|August 23, 2023
Combining Super Learner with high-dimensional propensity score to improve confounding adjustment: A real-world application in chronic lymphocytic leukemiaNeil Dhopeshwarkar, Wei Yang, Sean Hennessy, et al.
Journal of Clinical Epidemiology|August 30, 2023
Prospective collaborative recommendation development: a novel model for more timely and trustworthy guidelinesElie A Akl, Adam Cuker, Reem A Mustafa, et al.
Blood Advances|September 8, 2020
Pharmacometric modeling to explore 4F-PCC dosing strategies for VKA reversal in patients with INR below 2Ravi Sarode, Katsuyuki Fukutake, Masahiro Yasaka, et al.
Journal of Thrombosis and Thrombolysis|January 19, 2016
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolismMaureen A Smythe, Jennifer Priziola, Paul P Dobesh, et al.
Annals of Hematology|September 10, 2021
Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysisPallavi Patwardhan, Adrienne Landsteiner, Lincy S Lal, et al.
Annals of Hematology|June 10, 2023
Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidenceAdam Cuker, Brian Buckley, Marie-Catherine Mousseau, et al.
American Journal of Hematology|May 11, 2024
Cost-effectiveness of sutimlimab in cold agglutinin diseaseSatoko Ito, Daniel Wang, Adriana Purcell, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|April 4, 2025
Rapid Determination of Xa Inhibitor Activity in Blood Using a Microfluidic Device that Measures Platelet Deposition and Fibrin Generation Under FlowJason M Rossi, Karen A Panckeri, Soumita Ghosh, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 14, 2019
Why plasma-derived factor VIII?Louis Aledort, Shannon L Carpenter, Adam Cuker, et al.
Pageof 26

Showing results (121-130 of 258) with videos related to

Sort By:
Pageof 26
Thrombosis and Haemostasis|January 31, 2014
Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgeryAdam Cuker, Lubica Rauova, Douglas Bolgiano, et al.
Pharmacoepidemiology and Drug Safety|August 23, 2023
Combining Super Learner with high-dimensional propensity score to improve confounding adjustment: A real-world application in chronic lymphocytic leukemiaNeil Dhopeshwarkar, Wei Yang, Sean Hennessy, et al.
Journal of Clinical Epidemiology|August 30, 2023
Prospective collaborative recommendation development: a novel model for more timely and trustworthy guidelinesElie A Akl, Adam Cuker, Reem A Mustafa, et al.
Blood Advances|September 8, 2020
Pharmacometric modeling to explore 4F-PCC dosing strategies for VKA reversal in patients with INR below 2Ravi Sarode, Katsuyuki Fukutake, Masahiro Yasaka, et al.
Journal of Thrombosis and Thrombolysis|January 19, 2016
Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolismMaureen A Smythe, Jennifer Priziola, Paul P Dobesh, et al.
Annals of Hematology|September 10, 2021
Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysisPallavi Patwardhan, Adrienne Landsteiner, Lincy S Lal, et al.
Annals of Hematology|June 10, 2023
Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidenceAdam Cuker, Brian Buckley, Marie-Catherine Mousseau, et al.
American Journal of Hematology|May 11, 2024
Cost-effectiveness of sutimlimab in cold agglutinin diseaseSatoko Ito, Daniel Wang, Adriana Purcell, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|April 4, 2025
Rapid Determination of Xa Inhibitor Activity in Blood Using a Microfluidic Device that Measures Platelet Deposition and Fibrin Generation Under FlowJason M Rossi, Karen A Panckeri, Soumita Ghosh, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 14, 2019
Why plasma-derived factor VIII?Louis Aledort, Shannon L Carpenter, Adam Cuker, et al.
Pageof 26